Literature DB >> 18375689

Epley and the slow boat from research to practice.

Paul Glasziou1, Carl Heneghan.   

Abstract

Mesh：

Year:  2008        PMID： 18375689     DOI： 10.1136/ebm.13.2.34-a

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  5 in total

1.  Can GPs diagnose benign paroxysmal positional vertigo and does the Epley manoeuvre work in primary care?

Authors:  Sarah Cranfield; Ian Mackenzie; Mark Gabbay
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

2.  Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome.

Authors:  Niels West; Søren Hansen; Martin Nue Møller; Sune Land Bloch; Mads Klokker
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-07       Impact factor: 2.503

Review 3.  A Different Approach of Dizziness in Older Patients: Away from the Diagnostic Dance between Patient and Physician.

Authors:  Otto R Maarsingh; Hanneke Stam; Henriëtte E van der Horst
Journal:  Front Med (Lausanne)       Date:  2014-12-01

4.  Use of canalith repositioning manoeuvres and vestibular rehabilitation: a GP survey.

Authors:  Vincent A van Vugt; Patria M Diaz Nerio; Johannes C van der Wouden; Henriëtte E van der Horst; Otto R Maarsingh
Journal:  Scand J Prim Health Care       Date:  2017-03-06       Impact factor: 2.581

5.  Effectiveness of the Epley's maneuver performed in primary care to treat posterior canal benign paroxysmal positional vertigo: study protocol for a randomized controlled trial.

Authors:  José Luis Ballve Moreno; Ricard Carrillo Muñoz; Iván Villar Balboa; Yolanda Rando Matos; Olga Lucia Arias Agudelo; Asha Vasudeva; Olga Bigas Aguilera; Jesús Almeda Ortega; Alicia Capella Guillén; Clara Johanna Buitrago Olaya; Xavier Monteverde Curto; Estrella Rodero Perez; Carles Rubio Ripollès; Pamela Catalina Sepulveda Palacios; Noemí Moreno Farres; Anabella María Hernández Sánchez; Carlos Martin Cantera; Rafael Azagra Ledesma
Journal:  Trials       Date:  2014-05-21       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.